Company Data
Freeline Therapeutics Holdings plc
Ticker
FRLN
Current Price
$6.48
Market Cap
$28.1M
Price Target
Refer to Report
Volume
328.0K
52wk Range
$ - $
Overview
Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.